Tivozanib Active Not Recruiting Phase 2 Trials for Recurrent Primary Peritoneal Cancer / Recurrent Fallopian Tube Cancer / Recurrent, Epithelial Ovarian Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01853644Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer